What sizes are available for Lactate Dehydrogenase LDHA Rabbit Monoclonal Antibody?

Lactate Dehydrogenase LDHA Rabbit Monoclonal Antibody is available in the following size(s): 100 µL.

Lactate Dehydrogenase LDHA Rabbit Monoclonal Antibody

Q: What is the catalog number for Lactate Dehydrogenase LDHA Rabbit Monoclonal Antibody?

The catalog number for Lactate Dehydrogenase LDHA Rabbit Monoclonal Antibody is orb547500.

Q: Is Lactate Dehydrogenase LDHA Rabbit Monoclonal Antibody in stock?

Lactate Dehydrogenase LDHA Rabbit Monoclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Anti-Lactate Dehydrogenase LDHA Rabbit Monoclonal Antibody. Tested in WB, IHC, ICC/IF, IP, Flow Cytometry applications. This antibody reacts with Human, Mouse, Rat.

Product Specifications

Product Name Alternative

L-lactate dehydrogenase A chain; LDH-A; 1.1.1.27; Cell proliferation-inducing gene 19 protein; LDH muscle subunit; LDH-M; Renal carcinoma antigen NY-REN-59; LDHA; PIG19

UniProt

P00338

Reactivity

Human, Mouse, Rat

Immunogen

A synthesized peptide derived from human Lactate Dehydrogenase

Target

L-lactate dehydrogenase A chain

Clonality

Monoclonal

Clone

BEHGX34

Conjugation

Unconjugated

Field of Research

Cancer Biology, Metabolism Research, Signal Transduction

Purification

Affinity-chromatography

Concentration

0.5mg/ml

Dilution

WB 1:500-2000 IHC 1:50-200 ICC/IF 1:50-200 IP 1:20 FC 1:20

Form

Liquid

Molecular Weight

95 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

FC, ICC, IF, IHC, IP, WB

Host or Source

Rabbit

Preservative

Rabbit IgG in stabilizing components, phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.